La Puente, CA, United States of America

Carol Chen

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Medtronic Minimed, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carol Chen. Retrieved from https://idiyas.com/inventor/carol-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carol Chen: A Pioneer in Glucose Monitoring Technology

Introduction: Carol Chen is an accomplished inventor based in La Puente, CA (US). She has made significant contributions to the field of medical technology, particularly in glucose monitoring systems. With a focus on noninvasive methods, her work aims to improve the lives of individuals managing diabetes.

Latest Patents: Carol holds 1 patent for her invention titled "Miniaturized Noninvasive Glucose Sensor and Continuous Glucose Monitoring System." This innovative system utilizes a photoacoustic sensor to estimate analyte concentration levels. The patent also describes training methods for enhancing the accuracy of the sensor based on received acoustic signals.

Career Highlights: Carol is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management technology. Her role involves developing advanced solutions that facilitate better glucose monitoring for patients. Her dedication to innovation has positioned her as a key player in the medical technology sector.

Collaborations: Throughout her career, Carol has collaborated with notable colleagues, including Li Zhou and Raymond M. Russell. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion: Carol Chen's contributions to glucose monitoring technology exemplify her commitment to improving healthcare through innovation. Her work not only advances medical technology but also enhances the quality of life for individuals with diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…